Aridis Pharmaceutical
Phil Lovalenti is a highly experienced professional in the pharmaceutical industry, currently serving as Senior Director of R&D at Aridis Pharmaceutical since 2020, leading CMC and product development for biologics and small molecules while managing tech transfers to CDMOs. Prior roles at Aridis include Director of R&D, focusing on formulation and device development. Phil's expertise extends to previous positions at Onyx Pharmaceuticals as Principal Engineer, MedImmune Vaccines as Principal Scientist, and various roles at Johnson & Johnson, Centocor, and Novo Nordisk, all emphasizing drug delivery technologies and process development. Phil holds both an MS and PhD in Chemical Engineering from Caltech and a BS in Chemical Engineering from The University of Akron.
This person is not in any teams
This person is not in any offices
Aridis Pharmaceutical
1 followers
Aridis Pharmaceuticals, Inc. is a biopharmaceutical company focused on the development of novel, differentiated therapies for infectious diseases. Complementing the product pipeline is a disruptive platform technology to discover rare, potent human monoclonal antibodies from patients. Their scientists and leadership team have a proven track record of innovation and successful drug development of therapeutic candidates from early discovery to commercial implementation.